Equities

Sareum Holdings PLC

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Sareum Holdings PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (GBX)18.50
  • Today's Change0.50 / 2.78%
  • Shares traded134.17k
  • 1 Year change-5.13%
  • Beta-0.0003
Data delayed at least 20 minutes, as of Feb 13 2026 17:05 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Cash flow in GBPView more

In 2025, Sareum Holdings PLC increased its cash reserves by 143.04%, or 2.09m. Cash Flow from Financing totalled 4.55m or -- of revenues. In addition the company used 2.55m for operations while cash from investing totalled 89.00k.
Cash flow per share-0.0362
Price/Cash flow per share--
Book value per share0.0169
Tangible book value per share0.0169
More ▼

Balance sheet in GBPView more

Sareum Holdings PLC has little financial risk as the capital structure does not rely on leverage.
Current ratio2.17
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.